TrademarkDir
ONCO/REVEAL
LIVE

Serial Number

87619643

Owner

Pillar Biosciences, Inc.

Attorney

Marcus Assefa

First Use Date

Mar 16, 2021

Filing Date

Sep 22, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ONCO/REVEAL Trademark

Serial Number: 87619643 • Registration: 6389562

ONCO/REVEAL is a trademark filed by Pillar Biosciences, Inc. on September 22, 2017. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Pillar Biosciences, Inc. (17 trademarks)

Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

September 22, 2017

Registration Date

June 15, 2021

First Use Anywhere

March 16, 2021

First Use in Commerce

March 16, 2021

Published for Opposition

March 20, 2018

Goods & Services

Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; medical diagnostic testing in the nature of providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 15, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 13, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 12, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 8, 2021 SUPC
USE AMENDMENT FILED
May 6, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
May 6, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2020 EXRA
SOU EXTENSION 5 GRANTED
Oct 30, 2020 EX5G
SOU EXTENSION 5 FILED
Oct 23, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 23, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2020 EXRA
SOU EXTENSION 4 GRANTED
Apr 16, 2020 EX4G
SOU EXTENSION 4 FILED
Apr 16, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 16, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2019 EXRA
CORRECTED NOA E-MAILED
Nov 14, 2019 NOAC
DIVISIONAL PROCESSING COMPLETE
Nov 13, 2019 DPCC
SOU EXTENSION 3 GRANTED
Nov 13, 2019 EX3G
DIVISIONAL REQUEST RECEIVED
Nov 11, 2019 DRRR
SOU EXTENSION 3 FILED
Nov 11, 2019 EXT3
TEAS REQUEST TO DIVIDE RECEIVED
Nov 11, 2019 ERTD
SOU TEAS EXTENSION RECEIVED
Nov 11, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2019 EXRA
CORRECTED NOA E-MAILED
May 30, 2019 NOAC
DIVISIONAL PROCESSING COMPLETE
May 29, 2019 DPCC
SOU EXTENSION 2 GRANTED
May 29, 2019 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 29, 2019 AITU
DIVISIONAL REQUEST RECEIVED
May 10, 2019 DRRR
SOU EXTENSION 2 FILED
May 10, 2019 EXT2
TEAS REQUEST TO DIVIDE RECEIVED
May 10, 2019 ERTD
SOU TEAS EXTENSION RECEIVED
May 10, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2018 EXRA
SOU EXTENSION 1 GRANTED
Nov 15, 2018 EX1G
SOU EXTENSION 1 FILED
Nov 15, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 15, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 15, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2017 NWOS
NEW APPLICATION ENTERED
Sep 26, 2017 NWAP

Related Trademarks

More from this Owner

VERSATILE

VERSATILE

VERSATILE

VERSATILE

DECISION MEDICINE

DECISION MEDICINE

DECISION MEDICINE

DECISION MEDICINE

MRDTECT

MRDTECT

MRDTECT

MRDTECT